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Objectives: Currently louse-borne relapsing fever (LBRF) is primarily found in limited endemic
foci in Ethiopia, Somalia and Sudan; no case of imported LBRF has been reported in Europe in
the 9 years prior to 2015. The aim of our paper is to describe a new case of imported LBRF
detected in Sicily, Italy, and to review all cases reported in migrants arrived in Europe in the
last 10 years.
Study design: Mini review of all published cases of louse-borne relapsing fever in Europe in
the last 10 years.
Methods: A computerized search without language restriction was conducted using PubMed
combining the terms ‘(louse-borne relapsing fever or LBRF or recurrentis) and (refugee or
Europe or migrant)’ without limits. Furthermore, the ‘Ahead-of-Print Articles’ of the top 10
journals (ranked by Impact factor e Web of Science) of Infectious diseases and of Epide-
miology were checked.
Results: Our search identified 26 cases of LBRF between July and October 2015 in migrants
recently arrived in Europe: 8 had been described in Italy; 1 in Switzerland; 2 in the
Netherlands; 15 in Germany. We describe data regarding the clinical characteristics,
diagnostic methods, therapy and outcome of these patients and of the new case.
Conclusions: LBRF by Borrelia recurrentis should be considered among the clinical hypotheses
in migrants presenting with fever, headache, chills, sweating, arthralgia, myalgia, dizzi-
ness, nausea and vomiting.
© 2016 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.restricted spirochaeta transmitted by the body louse Ped-
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p u b l i c h e a l t h 1 3 9 ( 2 0 1 6 ) 2 2e2 6 23distinguished from tick-borne relapsing fever (TBRF) that is
caused by several Borrelia species transmitted to humans by
the bite of soft ticks of the genus Ornithodoros. TBRF is
characterized by recurrent bouts of fever, headache, and
malaise. B. recurrentis is closely related to Borrelia duttonii, one
of the 23 species of Borrelia currently implicated in TBRF, both
are human specific unlike the other Borrelia which have an
animal host.
In the first half of the twentieth century, major outbreaks
of LBRF occurred in Eastern Europe, the Balkans, former Soviet
Union and Africa, linked with periods of war and famine. The
geographical distribution of LBRF has reduced due to im-
provements in living standards. Currently, the disease is pri-
marily found in limited endemic foci in Ethiopia, but also in
Somalia and Sudanwhere, according to recent studies, LBRF is
among the top 10 causes of hospital admission nowadays.4,13
LBRF can be severe and death occurs in 10%e40% of cases in
the absence of appropriate treatment, and in 2%e5% of
treated patients.13 The aim of our paper was to describe a case
of imported LBRF detected in Sicily, Italy, and to review all
published cases of LBRF by B. recurrentis reported in migrants
arrived in Europe in the last 10 years. We underline the
epidemiology of this potentially re-emerging and serious dis-
ease in the context of a recent increase in refugees from East
Africa travelling to Europe.Methods
To review all cases of LBRF by B. recurrentis reported in mi-
grants arrived in Europe in the last ten years a computerized
search without language restriction was conducted using
PubMed combining the terms ‘(louse-borne relapsing fever or
LBRF or recurrentis) and (refugee or Europe or migrant)’
without limits. Furthermore, the ‘Ahead-of-Print Articles’ of
the top 10 journals (ranked by Impact factoreWeb of Science)
of Infectious diseases and of Epidemiology were checked.Results
A 26-year-old man from Somalia who arrived in Lampedusa,
Sicily, Italy, on December 24, 2015 was admitted to the Uni-
versity Hospital of Palermo 2 days later because of high fever,
headache, and general malaise, which developed 2 days after
his arrival. Blood analyses showed increased aspartate
aminotransferase and alanine aminotransferase levels (263 U/
l and 115 U/l, respectively), thrombocytopaenia (45,000 plate-
lets/ml), mild anaemia (haemoglobin level 10.8 g/l), elevated C-
reactive protein (74.9 mg/dl), elevated creatinine (4.72 mg/dl)
and blood urea nitrogen levels (132 mg/dl). Antigen-based
malaria rapid diagnostic tests were negative, blood cultures
were performed, and doxycycline 100 mg twice a day and
intravenous hydration was administered. The day after, tak-
ing in consideration the recently reported cases of LBRF in
refugees coming from East Africa, blood smears were per-
formed to search spirochaete together with a broad-range
bacterial PCR followed by partial sequencing of the 16S rRNA
gene. Blood smears were negative for spirochaete, while par-
tial sequencing of the 16S rRNA gene identified B. recurrentis.The patient recovered after treatment with doxycycline
(100 mg/twice a day) and intravenous hydration for 10 days.
Our search identified five publications reporting 26 cases of
LBRF between July and October 2015 in migrants recently
arrived in Europe: eight had been described in Italy (three in
Sicily and five in Piedmont); one in Switzerland; two in the
Netherlands; 15 in Germany (Bavaria).3,8,10,11,12 Data regarding
the clinical characteristics, diagnostic methods, therapy and
outcome of these patients and of the new case we report, are
analytically listed in Table 1.
The majority of cases (21) involved Somali people, five
cases Eritrean people, one case an Ethiopian patient. Themost
frequent migration route chosen by migrants was that from
East Africa, through Sudan and Libya, to North Africa and
eventually Europe. Travel duration ranged from a few weeks
to 1 year and all migrants reported to have been exposed to
very poor and overcrowded living conditions during travel.
Two patients, among those described in Italy, were long-term
residents in Italy, and they denied recent travel to Africa, so
they probably acquired the infection sharing the same house
of the newly arrived refugees. In 12 of the 17 patients with
available information, onset of symptoms was after arrival in
the country of destination. All the patients were young and
male.
Infestation with lice was present in seven cases and two
patients had head lice. All the cases had similar clinical pre-
sentation characterized by malaise, fever, headache, myalgia;
five had vomiting and three abdominal pain; only one patient
was afebrile. The outcome was good in all but one case who
died ofmulti-organ failure after initiation of antibiotic therapy
despite intensive care treatment.
In all cases found in the literature the diagnosis was based
on clinical symptoms and visible spirochaetes on Giemsa
stained blood films. PCR targeting 16S rRNA, flab, and glpQ
followed by sequencing confirmed cases as being caused by B.
recurrentis. All patients except one received antibiotic treat-
ment with doxycycline and 12 cases doxycycline plus ceftri-
axone. Jarisch-Herxheimer reaction (JHR) occurred in 15 (58%)
patients.Discussion
LBRF by B. recurrentis is a recurrent febrile illness with variable
periods of apyrexia between the febrile episodes, accompa-
nied by non-specific symptoms as headache, arthralgias and
myalgias. Hence, presentation of LBRF may resemble many
other serious infections as malaria, leptospirosis, tick-borne
recurrentis fever, typhoid fever.
Our research shows that cases of imported LBRF have only
been reported since July 2015. This can be explained by the
massive increase of refugees from LBRF-endemic areas since
2014.
From 2014 significant changes in migratory flows from
Libyan coast to Sicily have been observed.
In the past, most migrants came from Nigeria, Ghana,
Senegal and other countries of West Africa, nowadays,
migratory flow mostly come from East Africa (Ethiopia, So-
malia, and Eritrea). Accordingly, LBRF by B. recurrentis should
be considered among the clinical hypotheses in migrants
Table 1 e Characteristics of LBRF among East African refugees, Europe, 2015.
Country (ref)
(note)
Age/sex Country
of origin
Clinical picture Infestation with
lice
Onset of
Symptoms
Microbial
Diagnosis
Therapy Outcome
Italy (Ciervo et al. 2016)3
(3 pts)
17/M Somalia Fever
Arthralgia
Myalgia
Confusion
Thrombocytopaenia
Anaemia
Hyponatraemia
Yes (head lice) After arrival (2 days
before hospital
admission)
Microscopy, NAT Doxycycline plus
ceftriaxone
Good
18/M Somalia Fever
Arthralgia
Myalgia
Thrombocytopaenia
Anaemia
Yes (head lice) After arrival (3 days
before hospital
admission)
Microscopy, NAT Doxycycline plus
ceftriaxone
Good
13/M Somalia Fever
Headache
Skin lesions
Thrombocytopaenia
Anaemia
ND After arrival (5 days
before hospital
admission)
Microscopy, NAT Ceftriaxone JHR
Switzerland (Goldenberger
et al. 2015)8
NR/M Eritrea Fever
Nausea
Headache
Bilateral flank pain
Anaemia
Thrombocytopaenia
ND After arrival (12 days
before hospital
admission)
Microscopy, NAT Doxycycline plus
ceftriaxone
Good
Netherlands (Wilting
et al. 2015)12 (2 pts)
NR/M Eritrea Headache
Dizziness
Right upper
quadrant pain
Myalgia
Fever
Anaemia
Thrombocytopaenia
Yes After arrival Microscopy, NAT Ceftriaxone switched
in doxycycline
JHR
NR/M Eritrea Headache
Fever
Cough
Elevated
transaminases
ND After arrival Microscopy, NAT Doxycycline JHR
Germany (Hoch
et al. 2015)10 (15 pts)
Median age
20 years/M
Somalia (12)
Eritrea (2)
Ethiopia (1)
Fever (14/15)
Headache (6/15)
Skin lesions (4/15)
Yes (4 pts) Before arrival (8 pts)
After arrival (2 pts)
Microscopy, NAT Doxycycline One patient
died JHR (10/15)
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Italy (Lucchini
et al. 2016)11
(5 pts)
20/M Somalia Fever
Vomiting
Headache
Thrombocytopaenia
ND After arrival Microscopy, NAT Doxycycline JHR
20/M Somalia Fever
Vomiting
Abdominal pain
Headache
Cough
Thrombocytopaenia
ND After arrival Microscopy, NAT Doxycycline plus
ceftriaxone
Good
26/M Somalia Fever
Headache
Myalgia
Chest pain
Itching
Thrombocytopaenia
ND After arrival Microscopy, NAT Doxycycline
switched to
ceftriaxone
JHR
27/M Somalia Fever
Vomiting
Headache
Myalgia
Lumbar pain
Severe thrombocytopaenia
ND In Italy since 2011 Microscopy, NAT Doxycycline Good
31/M Somalia Fever
Abdominal pain
Vomiting
Diarrhoea
Headache
Thrombocytopaenia
Elevated transaminases
ND In Italy since 2012 Microscopy, NAT Doxycycline Good
Present case 26/M Somalia Fever Thrombocytopaenia
Headache
Acute renal failure
ND After arrival Microscopy, NAT Doxycycline Good
ND: not detected; NAT: nucleic acid test; JHR: JarischeHerxheimer reaction.
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p u b l i c h e a l t h 1 3 9 ( 2 0 1 6 ) 2 2e2 626presenting with fever, headache, chills, sweating, arthralgia,
myalgia, dizziness, nausea and vomiting.5
Thin and thick blood smears are the gold standard diag-
nostic technique for relapsing fever as for malaria and should
be performed at admission before starting antibiotic therapy.
In our case the blood smear was negative for spirochaetes
probably because the patient had received one dose of
doxycycline.
Nucleic acid detection of Borrelia is carried out in research
settings and can be used to support the clinical diagnosis.2,6,7
Regarding treatment, penicillins and tetracyclines, usually in
a single dose, are the antibiotics of choice for LBRF. Outcome is
usually good if prompt antibiotic treatment is administered.
Anti-spirochaetes therapy is often associated with the poten-
tially lethal JHR. JHR is a transient immunological phenomenon
seen commonly in patients during treatment for infection by
spirochaetes, and it manifests clinically with short-term
constitutional symptoms such as fever, chills, headache and
myalgias,besidesexacerbationofexistingcutaneous lesions. In
our review 15 out of 27 (58%) patients developed JHRs during
treatmentandmostof themhadbeentreatedwithdoxycycline.
Of note, a recent meta-analysis of five randomized controlled
trials, performed in Ethiopia, comparing the rate of JHRs in
patients with LBRF, treated with either penicillin or tetracy-
cline, showed a significant benefit in favour of penicillin.9
In consideration of the increasing number of refugees from
LBRF-endemic areas observed in Europe since 2014, early
detection, notification, and timely implementation of public
health measures are needed in order to reduce the risk of
outbreaks.Author statements
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